Holen Sie sich die Stockscreener-App
2.44
4.27%
0.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$2.34
Offen:
$2.34
24-Stunden-Volumen:
56,325
Relative Volume:
0.26
Marktkapitalisierung:
$73.78M
Einnahmen:
$193.67M
Nettoeinkommen (Verlust:
$4.82M
KGV:
17.39
EPS:
0.1403
Netto-Cashflow:
$15.53M
1W Leistung:
+7.02%
1M Leistung:
-2.01%
6M Leistung:
-70.17%
1J Leistung:
-75.96%
1-Tages-Spanne:
$2.34
$2.47
1-Wochen-Bereich:
$2.215
$2.48
52-Wochen-Spanne:
$1.66
$10.46
Zynex Inc Stock (ZYXI) Company Profile
Firmenname
Zynex Inc
Sektor
Branche
Telefon
(800)-495-6670
Adresse
9655 MAROON CIRCLE, ENGLEWOOD, CO
Vergleichen Sie ZYXI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 9.30 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.31 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.7364 | 130.22M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1496 | 346.50M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.24 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
42.12 | 0 | 0 | 0 | 0 | 0.00 |
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2025-03-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-02-28 | Bestätigt | B. Riley Securities | Buy |
| 2021-07-16 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2021-03-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-02-26 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-28 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2020-09-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-09-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-29 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-07-20 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-13 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-07-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2020-05-19 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-04-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-09-23 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Zynex Inc Aktie (ZYXI) Neueste Nachrichten
What analysts say about Zynex Inc. stockExceptional gains - jammulinksnews.com
Zynex Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
Is Zynex Inc. a good long term investmentHigh-velocity capital appreciation - jammulinksnews.com
Zynex Sets Second Quarter 2025 Earnings Call - 富途牛牛
What drives Zynex Inc. stock priceRapid wealth accumulation - jammulinksnews.com
Zynex Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
(ZYXI) On The My Stocks Page - news.stocktradersdaily.com
Muscle Stimulation Devices Market Future Business - openPR.com
Why Zynex Inc. stock attracts strong analyst attentionFast Growing Stocks - Newser
RBC Capital Lowers Zynex Target to $3.00, Maintains 'Sector Perform' Rating - AInvest
Royal Bank Of Canada Issues Pessimistic Forecast for Zynex (NASDAQ:ZYXI) Stock Price - MarketBeat
Zynex stock price target lowered to $3 by RBC amid payment issues - Investing.com Nigeria
Zynex (ZYXI) Target Price Lowered by RBC Capital, Maintains Rati - GuruFocus
RBC Capital Downgrades Zynex to Sector Perform, PT to $3 from $4. - AInvest
Zynex Inc. shares rise 2.94% intraday after RBC cuts price target to $3. - AInvest
RBC Cuts Price Target on Zynex to $3 From $4, Keeps Sector Perform Rating - MarketScreener
What makes Zynex Inc. stock price move sharplyValue Pick Scanner - Newser
Zynex: New CEO Steven Dyson shares his vision – ICYMI - Proactive financial news
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Execs Of Device Co. Made $6M From Insider Trading, Suit Says - Law360
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Zynex Shareholder Sues Board, Execs Over Insurer’s Payment Pause - Bloomberg Law News
Zynex names Steven Dyson new CEO - ColoradoBiz
Zynex appoints Steven Dyson as CEO; founder Thomas Sandgaard moves to Chairman role to steer vision - Proactive Investors
Zynex CEO Thomas Sandgaard discusses leadership transitionICYMI - Proactive financial news
Zynex says Tricare payment suspension to remain in place - MSN
Zynex confirms continued temporary payment suspension from Tricare - Proactive financial news
Zynex Appoints Steven Dyson as New CEO - The Globe and Mail
Zynex Says Tricare Payment Suspension Will Continue Amid Review - MarketScreener
Zynex stock falls after Tricare extends payment suspension - Investing.com
Zynex stock falls after Tricare extends payment suspension By Investing.com - Investing.com India
Zynex, Inc. (ZYXI): Can Strategic Shifts and Liquidity Maneuvers Turn the Tide on Tricare's Stranglehold? - AInvest
Tricare Temporary Payment Suspension Update – Company Announcement - Financial Times
Medtech firm replacing CEO as it grapples with revenue loss, legal challenges - The Business Journals
Zynex appoints Steven Dyson as CEO, founder Thomas Sandgaard transitions to Chairman role - Proactive financial news
H.C. Wainwright reiterates Buy rating on Zynex stock with $8 price target - Investing.com India
Zynex appoints Steven Dyson as new CEO effective August 18 By Investing.com - Investing.com Canada
Zynex Announces Steven Dyson as New CEO - GuruFocus
Zynex taps Steve Dyson as chief executive officer - Proactive financial news
Zynex, Inc.(NasdaqGS: ZYXI) dropped from Russell Small Cap Comp Growth Index - MarketScreener
Zynex Announces Steven Dyson as New CEO | ZYXI Stock News - GuruFocus
Zynex secures UK patent for noninvasive sepsis monitoring device - Investing.com
Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis - PR Newswire
Zynex awarded UK patent for non-invasive sepsis monitoring technology | NASDAQ:ZYXI - Proactive financial news
Zynex Announces Workforce Reduction for Cost Savings - TipRanks
Finanzdaten der Zynex Inc-Aktie (ZYXI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.33%
9.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):